Related references
Note: Only part of the references are listed.Dominant Expansion of a Cryptic Subclone with an Abnormal Karyotype in B Lymphoblastoid Cell Lines during Culture
I. Danjoh et al.
CYTOGENETIC AND GENOME RESEARCH (2013)
Molecular characterization of mucinous ovarian tumours supports a stratified treatment approach with HER2 targeting in 19% of carcinomas
Michael S. Anglesio et al.
JOURNAL OF PATHOLOGY (2013)
Prognostic and therapeutic impact of the chromosome 20q13.2 ZNF217 locus amplification in ovarian clear cell carcinoma
Mohammed Tanjimur Rahman et al.
CANCER (2012)
The Changing View of High-Grade Serous Ovarian Cancer
Els M. J. J. Berns et al.
CANCER RESEARCH (2012)
Treatment of Ovarian Cancer in Young Women
David M. Gershenson
CLINICAL OBSTETRICS AND GYNECOLOGY (2012)
DNA profiling analysis of endometrial and ovarian cell lines reveals misidentification, redundancy and contamination
Christopher Korch et al.
GYNECOLOGIC ONCOLOGY (2012)
Prevalence of Loss of Expression of DNA Mismatch Repair Proteins in Primary Epithelial Ovarian Tumors
Fang-I Lu et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY (2012)
BRCA Mutation Frequency and Patterns of Treatment Response in BRCA Mutation-Positive Women With Ovarian Cancer: A Report From the Australian Ovarian Cancer Study Group
Kathryn Alsop et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Accumulative copy number increase of MET drives tumor development and histological progression in a subset of ovarian clear-cell adenocarcinomas
Sohei Yamamoto et al.
MODERN PATHOLOGY (2012)
BRCA1 and BRCA2 mutations correlate with TP53 abnormalities and presence of immune cell infiltrates in ovarian high-grade serous carcinoma
Jessica N. McAlpine et al.
MODERN PATHOLOGY (2012)
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
Jordi Barretina et al.
NATURE (2012)
Natural history and outcome of mucinous carcinoma of the ovary
Maria B. Schiavone et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2011)
Fallopian Tube Correlates of Ovarian Serous Borderline Tumors
Anna R. Laury et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2011)
Histotype predicts the curative potential of radiotherapy: the example of ovarian cancers
K. D. Swenerton et al.
ANNALS OF ONCOLOGY (2011)
IL6-STAT3-HIF Signaling and Therapeutic Response to the Angiogenesis Inhibitor Sunitinib in Ovarian Clear Cell Cancer
Michael S. Anglesio et al.
CLINICAL CANCER RESEARCH (2011)
Copy Number Aberrations in Benign Serous Ovarian Tumors: A Case for Reclassification?
Sally M. Hunter et al.
CLINICAL CANCER RESEARCH (2011)
Genomic Analysis Reveals the Molecular Heterogeneity of Ovarian Clear Cell Carcinomas
David S. P. Tan et al.
CLINICAL CANCER RESEARCH (2011)
Clear cell carcinoma of the ovary: A report from the first Ovarian Clear Cell Symposium, June 24th, 2010
Michael S. Anglesio et al.
GYNECOLOGIC ONCOLOGY (2011)
Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer-Shifting the paradigm
Robert J. Kurman et al.
HUMAN PATHOLOGY (2011)
The Origin of Ovarian Carcinomas: A Unifying Hypothesis
Nelly Auersperg
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY (2011)
Biomarker Expression in Pelvic High-grade Serous Carcinoma: Comparison of Ovarian and Omental Sites
Martin Koebel et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY (2011)
Endometriosis and Ovarian Cancer: A Review of Clinical, Pathologic, and Molecular Aspects
Jian-Jun Wei et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY (2011)
Calculator for ovarian carcinoma subtype prediction
Steve E. Kalloger et al.
MODERN PATHOLOGY (2011)
Gene amplification and protein overexpression of MET are common events in ovarian clear-cell adenocarcinoma: their roles in tumor progression and prognostication of the patient
Sohei Yamamoto et al.
MODERN PATHOLOGY (2011)
Integrated genomic analyses of ovarian carcinoma
D. Bell et al.
NATURE (2011)
COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer
Simon A. Forbes et al.
NUCLEIC ACIDS RESEARCH (2011)
The Hippo pathway transcriptional co-activator, YAP, is an ovarian cancer oncogene
X. Zhang et al.
ONCOGENE (2011)
Morphological subtypes of ovarian carcinoma: a review with emphasis on new developments and pathogenesis
W. Glenn McCluggage
PATHOLOGY (2011)
deFuse: An Algorithm for Gene Fusion Discovery in Tumor RNA-Seq Data
Andrew McPherson et al.
PLOS COMPUTATIONAL BIOLOGY (2011)
Rethinking ovarian cancer: recommendations for improving outcomes
Sebastian Vaughan et al.
NATURE REVIEWS CANCER (2011)
Diagnosis of Ovarian Carcinoma Cell Type is Highly Reproducible A Transcanadian Study
Martin Koebel et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2010)
The Origin and Pathogenesis of Epithelial Ovarian Cancer: A Proposed Unifying Theory
Robert J. Kurman et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2010)
DNA Copy Numbers Profiles in Affinity-Purified Ovarian Clear Cell Carcinoma
Kuan-Ting Kuo et al.
CLINICAL CANCER RESEARCH (2010)
When 'never-events' occur despite adherence to clinical guidelines: The case of venous thromboembolism in clear cell cancer of the ovary compared with other epithelial histologic subtypes
Linda R. Duska et al.
GYNECOLOGIC ONCOLOGY (2010)
Tumor type and substage predict survival in stage I and II ovarian carcinoma: Insights and implications
Martin Koebel et al.
GYNECOLOGIC ONCOLOGY (2010)
Check your cultures! A list of cross-contaminated or misidentified cell lines
Amanda Capes-Davis et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Prognostic Relevance of Uncommon Ovarian Histology in Women With Stage III/IV Epithelial Ovarian Cancer
Helen J. Mackay et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2010)
Differences in Tumor Type in Low-stage Versus High-stage Ovarian Carcinomas
Martin Koebel et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY (2010)
Serous Tubal Intraepithelial Carcinoma: Diagnostic Reproducibility and its Implications
Joseph W. Carlson et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY (2010)
Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovary
Ashour Ahmed Ahmed et al.
JOURNAL OF PATHOLOGY (2010)
The biological and clinical value of p53 expression in pelvic high-grade serous carcinomas
Martin Koebel et al.
JOURNAL OF PATHOLOGY (2010)
Researchers find a new cancer gene and a possible link between ovarian cancer and endometriosis
[Anonymous]
WOMENS HEALTH (2010)
Primary ex vivo cultures of human fallopian tube epithelium as a model for serous ovarian carcinogenesis
K. Levanon et al.
ONCOGENE (2010)
Frequent Mutations of Chromatin Remodeling Gene ARID1A in Ovarian Clear Cell Carcinoma
Sian Jones et al.
SCIENCE (2010)
ARID1A Mutations in Endometriosis-Associated Ovarian Carcinomas
Kimberly C. Wiegand et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Ovarian Low-grade and High-grade Serous Carcinoma Pathogenesis, Clinicopathologic and Molecular Biologic Features, and Diagnostic Problems
Russell Vang et al.
ADVANCES IN ANATOMIC PATHOLOGY (2009)
Frequent Activating Mutations of PIK3CA in Ovarian Clear Cell Carcinoma
Kuan-Ting Kuo et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
HER2 overexpression and amplification is present in a subset of ovarian mucinous carcinomas and can be targeted with trastuzumab therapy
Jessica N. McAlpine et al.
BMC CANCER (2009)
PPM1D Is a Potential Therapeutic Target in Ovarian Clear Cell Carcinomas
David S. P. Tan et al.
CLINICAL CANCER RESEARCH (2009)
Intercepting pelvic cancer in the distal fallopian tube: Theories and realities
Christopher P. Crum
MOLECULAR ONCOLOGY (2009)
Microsatellite instability and mismatch repair protein defects in ovarian epithelial neoplasms in patients 50 years of age and younger
Kristin C. Jensen et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2008)
A Limited Panel of Immunomarkers Can Reliably Distinguish Between Clear Cell and High-grade Serous Carcinoma of the Ovary
Martin Köbel et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2008)
Endometrioid epithelial ovarian cancer - 20 years of prospectively collected data from a single center
Dawn J. Storey et al.
CANCER (2008)
Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome
Richard W. Tothill et al.
CLINICAL CANCER RESEARCH (2008)
Neoadjuvant chemotherapy for low-grade serous carcinoma of the ovary or peritoneum
Kathleen M. Schmeler et al.
GYNECOLOGIC ONCOLOGY (2008)
Tumor cell type can be reproducibly diagnosed and is of independent prognostic significance in patients with maximally debulked ovarian carcinoma
C. Blake Gilks et al.
HUMAN PATHOLOGY (2008)
Mutation of ERBB2 Provides a Novel Alternative Mechanism for the Ubiquitous Activation of RAS-MAPK in Ovarian Serous Low Malignant Potential Tumors
Michael S. Anglesio et al.
MOLECULAR CANCER RESEARCH (2008)
Ovarian Carcinoma Subtypes Are Different Diseases: Implications for Biomarker Studies
Martin Koebel et al.
PLOS MEDICINE (2008)
Ovarian cancer at young age:: the contribution of mismatch-repair defects in a population-based series of epithelial ovarian cancer before age 40
K. Domanska et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2007)
Lessons from BRCA: The Tubal Fimbria Emerges as an Origin for Pelvic Serous Cancer
Christopher P. Crum et al.
CLINICAL MEDICINE & RESEARCH (2007)
Mixed clear cell and endometrioid carcinoma arising in parietal endometriosis
Kais Razzouk et al.
GYNECOLOGIC AND OBSTETRIC INVESTIGATION (2007)
Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: A kin-cohort study in Ontario, Canada
Harvey A. Risch et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
Molecular genetic evidence that endometriosis is a precursor of ovarian cancer
Amanda H. Prowse et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Ovarian cancer incidence in the United States, 1992-1999
JT Quirk et al.
GYNECOLOGIC ONCOLOGY (2005)
Mucinous epithelial ovarian cancer: A separate entity requiring specific treatment
V Hess et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Characterization of intraperitoneal, orthotopic, and metastatic xenograft models of human ovarian cancer
TJ Shaw et al.
MOLECULAR THERAPY (2004)
Microsatellite instability and expression of hMLH1 and hMSH2 proteins in ovarian endometrioid cancer
JS Liu et al.
MODERN PATHOLOGY (2004)
Mutation of the PIK3CA gene in ovarian and breast cancer
IG Campbell et al.
CANCER RESEARCH (2004)
Microsatellite instability and alteration of the expression of hMLH1 and hMSH2 in ovarian clear cell carcinoma
KQ Cai et al.
HUMAN PATHOLOGY (2004)
Histopathologic features of genetically determined ovarian cancer
PA Shaw et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY (2002)
Survival among US women with invasive epithelial ovarian cancer
V McGuire et al.
GYNECOLOGIC ONCOLOGY (2002)
Identification of a p53 response element in the promoter region of the hMSH2 gene required for expression in A2780 ovarian cancer cells
CT Warnick et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Precursor lesions of ovarian epithelial malignancy
KM Feeley et al.
HISTOPATHOLOGY (2001)
Endometriosis: candidate genes
IG Campbell et al.
HUMAN REPRODUCTION UPDATE (2001)
Characterization of MLH1 and MSH2 DNA mismatch repair proteins in cell lines of the NCI anticancer drug screen
P Taverna et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2000)
Evidence that endometriosis behaves in a malignant manner
EJ Thomas et al.
GYNECOLOGIC AND OBSTETRIC INVESTIGATION (2000)
Molecular genetic defects in endometriosis
EJ Thomas et al.
GYNECOLOGIC AND OBSTETRIC INVESTIGATION (2000)
Share Paper
